Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic, Randomized, Controlled Study Evaluating The Impact Of Access To Smoking Cessation Treatment Reimbursement On The Proportion Of Successful Quitters In A Canadian Population Of Smokers Motivated To Quit

NCT00818207 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00818207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00818207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic, Randomized, Controlled Study Evaluating The Impact Of Access To Smoking Cessation Treatment Reimbursement On The Proportion Of Successful Quitters In A Canadian Population Of Smokers Motivated To Quit
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
September 30, 2010
Enrollment
1,380 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

insurance coverage, smoking cessation